Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

September same-store sales dip at Rite Aid

Same-store sales improved but were still down slightly in September at Rite Aid Corp. The drug store chain reported Thursday that for the four weeks ended Sept. 25, same-store sales dipped 0.9% year over year. That result was a bit better than the 1% decline in August but continued a series

CAMP HILL, Pa. — Same-store sales improved but were still down slightly in September at Rite Aid Corp.

The drug store chain reported Thursday that for the four weeks ended Sept. 25, same-store sales dipped 0.9% year over year. That result was a bit better than the 1% decline in August but continued a series of same-store sales decreases since the retailer posted virtually flat same-store sales in March. Its last reported same-store sales gain was in May 2009.

In September, same store sales fell 0.3% in the front end and 1.2% in the pharmacy. Rite Aid noted that the pharmacy same-store results included a 233-basis-point negative impact from new generic drug introductions and that prescriptions filled at comparable stores decreased 1.3%.

Total drug store sales for September were down 2% to $1.90 billion from $1.94 billion a year earlier, Rite Aid said.

For the 30-week year-to-date period ended Sept. 25, Rite Aid’s same-store sales declined 1.2% over the prior-year time span. That result reflected same-store decreases of 1% in the front end and 1.3% in the pharmacy, where comparable-store prescriptions filled were down 1.8% from the year-ago period.

Overall drug store sales for the 30 weeks came in at nearly $14.41 billion, down 2.3% from $14.74 billion in the prior-year span.

As of Sept. 25, Rite Aid operated 4,742 drug stores, compared with 4,809 stores a year ago.

Latest

RFK Jr. under fire at senate hearing amid CDC turmoil

RFK Jr. under fire at senate hearing amid CDC turmoil

Kennedy appeared yesterday before the Senate finance committee to testify on his Make America Healthy Again agenda after a tumultuous few weeks that ended with more than 1,000 current and former health agency employees accusing him of “putting the health of all Americans at risk”.